Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 diabetes (SCORE-IT): a patient and healthcare professional consensus on a core outcome set for type 2 diabetes.
Nicola L HarmanJohn P H WildingDave CurryJames HarrisJennifer LogueR John PembertonLeigh PerreaultGareth ThompsonSean TunisPaula R Williamsonnull nullPublished in: BMJ open diabetes research & care (2019)
Implementation of the core outcome set in future trials will ensure that outcomes of importance to all stakeholders are measured and reported, enhancing the relevance of trial findings and facilitating the comparison of results across trials.
Keyphrases
- type diabetes
- healthcare
- glycemic control
- clinical trial
- study protocol
- randomized controlled trial
- cardiovascular disease
- open label
- primary care
- systematic review
- case report
- insulin resistance
- phase iii
- current status
- phase ii
- quality improvement
- double blind
- adipose tissue
- metabolic syndrome
- placebo controlled
- skeletal muscle
- social media